100% MedTech. Nothing Else.
Commercial Strategy & M&A Advisory for MedTech Leaders
We help medical device companies find acquisition targets, enter new markets, and scale across EMEA. Hands-on. Conflict-free. Senior-level attention from day one.
EUR0M+
P&L Managed
0%
Revenue Growth Delivered
0%
Market Share Expansion
EUR0M+
M&A Integrated
Active across DACH, Nordics, Benelux, and UK
What We Do
Specialized advisory for medical device companies, PE/VC investors, and healthcare innovators.
Commercial Strategy & Go-to-Market Advisory
Data-driven market entry and growth strategies for medical device companies expanding across EMEA.
FindAcquisition Target Screening
We identify and evaluate MedTech acquisition targets that fit your growth strategy.
EvaluateM&A Commercial Due Diligence
Commercial due diligence and value creation planning for PE funds and strategic acquirers in MedTech.
EvaluateVendor Due Diligence
Sell-side commercial due diligence that prepares your MedTech business for exit, presenting your commercial strengths through the buyer's lens.
GrowBuy & Build Strategy
Post-acquisition growth planning for PE-backed MedTech platforms running serial acquisition strategies across EMEA.
GrowExit Readiness & Value Creation
We prepare MedTech portfolio companies for exit by strengthening commercial fundamentals and building a compelling equity story.
Our Methodology
The BHAG Compass
Five phases that cover the full lifecycle of MedTech commercial growth, from finding targets to leading organizations.
Find
Target screening, market mapping, competitive intelligence
Evaluate
Commercial DD, vendor DD, AI & digital DD, regulatory assessment
Enter
Market entry strategy, geographic expansion, channel architecture
Grow
Value creation, Buy & Build, exit readiness, portfolio optimization
Lead
Interim executive, advisory board, expert network
About the Founder
Shahram Khorsand
Founder & Managing Director
20+ years of MedTech commercial leadership. SSE MBA. Board member of several MedTech companies. Helping medical device companies scale across EMEA.
Education
MBA, Stockholm School of Economics (SSE)
MSc, Computer Engineering
Board positions
Board member of several MedTech companies across Europe
Selected Transactions & Engagements
Anonymized examples of our work across MedTech verticals.
Nordic Market Entry for Surgical Device Company
27% revenue growth
Surgical
Commercial Due Diligence for PE Fund
EUR 15M upside identified
Wound Care
Interim Country Manager, MedTech Distributor
EUR 130M+ integration led
Distribution
EMEA Launch Strategy for IoT Medical Device
3-market launch plan
Digital Health
Post-Merger Commercial Integration
19% market share expansion
Multi-segment
What Clients Say
Shahram brought exactly the operator perspective we needed during our MedTech CDD. He asked the questions our strategy consultants missed, because he had actually run these types of businesses himself.
Investment Director
Nordic PE Fund
We brought BHAG in as interim country manager during a tough integration. Shahram stabilized the team, kept our key accounts, and left behind a stronger organization than he found. You do not see that often in interim roles.
CEO
European MedTech Distributor
The market entry strategy BHAG delivered for our Nordic expansion was practical and specific. No generic frameworks. Actionable plans built on real knowledge of how Nordic healthcare procurement works.
VP Commercial
Surgical Device Company
Sectors We Cover
Focused expertise across MedTech verticals.
Surgical Instruments & Consumables
Wound Care & Advanced Therapies
Orthopedics & Implants
Diagnostics & IVD
Digital Health & SaMD
Medical Distribution & Channel
Patient Monitoring & IoT
Dental & Ophthalmology
Insights
Perspectives on MedTech commercial strategy, M&A, and market dynamics.
5 Mistakes MedTech Companies Make Entering the Nordic Market
The Nordics look deceptively simple. Similar languages, high GDP, universal healthcare. But the commercial reality is more complex than most MedTech companies expect.
Read article →MDR is Reshaping European MedTech Distribution. Here is How.
The European Medical Device Regulation is not just a compliance exercise. It is fundamentally changing which products reach the market and through which channels.
Read article →Why Your MedTech PE Deal Needs Commercial Due Diligence
Financial models tell you what happened. Commercial due diligence tells you whether it will continue. For MedTech acquisitions, the difference is material.
Read article →Ready to scale your MedTech business across EMEA?
Whether you need a go-to-market strategy, commercial due diligence, or interim leadership, we are here to help.
Get in Touch